Stocktoria
COGNITION THERAPEUTICS INC CGTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-08
COGNITION THERAPEUTICS INC statistics & valuation
Market cap$100.2M
P / B2.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -48.5% | -112.4% | -73.3% | -42.4% | -19.8% |
| Return on equity | -68.5% | -181.2% | -105.4% | -53.2% | -22.9% |
| Current ratio | 3.45 | 2.65 | 3.37 | 6.11 | 7.50 |
Source: SEC EDGAR filings · CIK 0001455365 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.